Literature DB >> 8416438

Hypothalamic-pituitary dysfunction after radiation for brain tumors.

L S Constine1, P D Woolf, D Cann, G Mick, K McCormick, R F Raubertas, P Rubin.   

Abstract

BACKGROUND: Patients with brain tumors who are treated with radiation frequently have growth hormone deficiency, but other neuroendocrine abnormalities are presumed to be uncommon.
METHODS: We studied endocrine function in 32 patients (age, 6 to 65 years) 2 to 13 years after they had received cranial radiotherapy for brain tumors. The doses of radiation to the hypothalamic-pituitary region ranged from 3960 to 7020 rad (39.6 to 70.2 Gy). Nine patients also received 1800 to 3960 rad (18.0 to 39.6 Gy) to the craniospinal axis. Serum concentrations of thyroid, gonadal, and pituitary hormones were measured at base line and after stimulation.
RESULTS: Nine patients (28 percent) had symptoms of thyroid deficiency, and 20 patients (62 percent) had low serum total or free thyroxine or total triiodothyronine concentrations. Of the 23 patients treated only with cranial radiation, 15 (65 percent) had hypothalamic or pituitary hypothyroidism. Of the nine patients who also received spinal (and thus direct thyroid) radiation, three (33 percent) had evidence of primary thyroid injury. Seven of the 10 postpubertal, premenopausal women (70 percent) had oligomenorrhea, and 5 (50 percent) had low serum estradiol concentrations. Three of the 10 men (30 percent) had low serum testosterone concentrations. Overall, 14 of the 23 postpubertal patients (61 percent) had evidence of hypogonadism. Mild hyperprolactinemia was present in 50 percent of the patients. Responses to stimulation with corticotropin-releasing hormone and corticotropin were normal in all patients except one, who had panhypothalamic dysfunction. However, serum 11-deoxycortisol responses to the administration of metyrapone were low in 11 of the 31 patients (35 percent) tested. Three of the 32 patients, (9 percent) had no endocrine abnormalities, 9 (28 percent) had an abnormal result on tests of thyroid, gonadal, prolactin, or adrenal function, 8 (25 percent) had abnormalities in two axes, 8 (25 percent) in three axes, and 4 (12 percent) in all four axes.
CONCLUSIONS: Cranial radiotherapy in children and adults with brain tumors frequently causes abnormal hypothalamic-pituitary function. The most frequent changes are hypothyroidism and gonadal dysfunction, although subtle abnormalities in adrenal function may also be present.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416438     DOI: 10.1056/NEJM199301143280203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  98 in total

Review 1.  Endocrine sequelae of cancer therapy in childhood.

Authors:  F B Diamond; B B Bercu
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  Sleep disturbances in adult survivors of childhood brain tumors.

Authors:  Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

Review 3.  Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management.

Authors:  A A Brandes; L M Pasetto; F Lumachi; S Monfardini
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

4.  The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience.

Authors:  Tamir Ailon; Christopher Dunham; Anne-Sophie Carret; Uri Tabori; P Daniel Mcneely; Shayna Zelcer; Beverley Wilson; Lucie Lafay-Cousin; Donna Johnston; David D Eisenstat; Marianna Silva; Nada Jabado; Karen Jane Goddard; Chris Fryer; Glenda Hendson; Cynthia Hawkins; Sandra Dunn; Stephen Yip; Ashutosh Singhal; Juliette Hukin
Journal:  Childs Nerv Syst       Date:  2014-11-13       Impact factor: 1.475

5.  Characteristics and determinants of adiposity in pediatric cancer survivors.

Authors:  Tracie L Miller; Stuart R Lipsitz; Gabriela Lopez-Mitnik; Andrea S Hinkle; Louis S Constine; M Jacob Adams; Carol French; Cynthia Proukou; Amy Rovitelli; Steven E Lipshultz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

6.  Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults.

Authors:  A Mukherjee; M Helbert; W D J Ryder; R Borrow; J R E Davis; S M Shalet
Journal:  Clin Exp Immunol       Date:  2009-02-10       Impact factor: 4.330

Review 7.  Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications.

Authors:  Monika L Metzger; Lillian R Meacham; Briana Patterson; Jacqueline S Casillas; Louis S Constine; Nobuko Hijiya; Lisa B Kenney; Marcia Leonard; Barbara A Lockart; Wendy Likes; Daniel M Green
Journal:  J Clin Oncol       Date:  2013-02-04       Impact factor: 44.544

Review 8.  [Hypophyseal coma].

Authors:  B L Herrmann; K Mann
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

9.  Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.

Authors:  Laura van Iersel; Zhenghong Li; Deo Kumar Srivastava; Tara M Brinkman; Kari L Bjornard; Carmen L Wilson; Daniel M Green; Thomas E Merchant; Ching-Hon Pui; Rebecca M Howell; Susan A Smith; Gregory T Armstrong; Melissa M Hudson; Leslie L Robison; Kirsten K Ness; Amar Gajjar; Kevin R Krull; Charles A Sklar; Hanneke M van Santen; Wassim Chemaitilly
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 10.  Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.

Authors:  H Irene Su; Yuton Tony Lee; Ronald Barr
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.